PUBLIC CONTRACT · 2023

Aquisição de Atezolizumab 1200 mg/20 ml, Alectinib 150 mg, Tocilizumab 162 mg e de Vismodegib 150 mg pelo Hospital de Santo Espírito da Ilha Terceira, E.P.E.R.

Contract value: €361,296.00
Signed on: 10 February 2023
Procedure: Direct award, general (Ajuste Direto Regime Geral)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9798602

PUBLISHED SUBJECT

Parties involved

Contracting body: HOSPITAL DE SANTO ESPÍRITO DA ILHA TERCEIRA, EPER
Awardee: ROCHE FARMACEUTICA QUIMICA, LDA
Place of performance: Portugal, Região Autónoma dos Açores, Angra do Heroismo
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: ROCHE FARMACEUTICA QUIMICA, LDA · Tax ID 500233810

Values and timeline

Contract price: €361,296.00
Procedure base price: €361,296.00
Total effective price: €259,779.12
Publication date: 14 February 2023
Award date: 25 January 2023
Signing date: 10 February 2023
Performance period: 365 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Direct award, general (Ajuste Direto Regime Geral)
Award criterion: Monofator
CPV code: 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
Legal basis: Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL 111-B/2017) e Lei n.º 30/2021, de 21.05 e DLR no 27/2015/A, de 29.12
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 6249188

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts